Delivery Order SPE2DB20D1100-SPE2DB25FB5B1

Award Date 4/2/25
Potential Completion Date 4/23/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 Firm Fixed Price delivery order contract covers the supply of the drug WELIREG 40 MG TABLET 90S. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,936.78 firm-fixed-price delivery order is for the supply of 4567409311 WELIREG 40 MG TABLET 90S, with a period of performance through March 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price delivery order contract is for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 25, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $17,368.14 to Amerisourcebergen Drug Corp for the supply of 4564762847 WELIREG 40 MG TABLET 90S. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of WELIREG 40 MG TABLET 90S. The contract, valued at $17,368.14, was awarded by the Medical Supply Chain division of the Defense Department. It is a firm fixed-price delivery order contract with a completion date of June 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to...
This federal contract award, valued at $17,968.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order that covers the supply of 4567585354 ! WELIREG 40 MG TABLET 90S, a medical product, under a firm fixed-price arrangement. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D3501|SPE2DB25FUF95, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of WELIREG 40 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $17,968.39. The contract is a Firm Fixed Price Delivery Order with a period of performance running through February 12, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $17,368.14, is for the delivery of 4565941918 WELIREG 40 MG TABLET 90S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for a comprehensive range...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,936.78, is for the delivery of WELIREG 40 MG TABLET 90S to support federal healthcare programs. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $17,968.39 and a completion date of January 6, 2025. It is a delivery order contract for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB5B1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,968.39 firm fixed-price delivery order is for the supply of WELIREG 40 MG TABLET 90S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any major subcontractors.

Generated 7/6/25, 12:45 AM